The nonpartisan Public Policy Institute of California has released the results of a statewide survey of Californians about ...

A drug that delivers chemotherapy directly to tumors has shown impressive activity against some of the hardest-to-reach cancer cells: those that have spread to the brain in patients with advanced ...

Five men, including three Bradford men, have been jailed for a total of 109 years for their part in a sophisticated plot which saw heroin worth more than £9m smuggled into the UK in bottles of ...

Thus, WDR5 is an excellent drug target candidate to treat MYC-related cancers. Previous Tansey and Fesik research resulted in the discovery of WDR5 inhibitors called WIN-site inhibitors ...

Merck's combination of a wide lineup of high-margin drugs and a pipeline of new drugs should ensure strong returns on invested capital over the long term. Further, following the divestment of the ...

Ease into the English language and Australian culture. We make learning English convenient, fun and practical. Get the latest with our exclusive in-language podcasts on your favourite podcast apps.

A new, oral ‘first in class’ experimental cancer drug has shown potent activity against cancer cells and caused shrinkage of hard-to-treat human ovarian tumours grown in mice, a new study shows. The ...

Norwich Crown Court heard police detected a smell of the drug and Clohisey told officers he had cannabis in the boot. David Barr, prosecuting, said police found 146g of cannabis, more than £1,000 ...

Merck reported second-quarter revenue and adjusted earnings that topped estimates as it saw strong sales from its blockbuster cancer drug Keytruda as well as other treatments in its oncology and ...

Another of the company’s mental health drugs, Rexulti (brexipiprazole) for maintenance treatment of schizophrenia saw sales increased by 24% to just over 2 million Danish kroner ($310 million).

Andrew Fein has given his Buy rating due to a combination of factors surrounding KalVista Pharmaceuticals’ prospects, particularly the potential of its leading drug candidate, sebetralstat.

(Reuters) - Cardinal Health raised its 2025 profit forecast on Wednesday betting on strong demand for branded and specialty medicines at its pharmaceuticals unit. Drug distributors have been ...